Archived Columns
Recent Posts
- Telitacicept eases Sjögren’s disease activity in Phase 3 trial
- Machine learning tool may help in diagnosing primary Sjögren’s
- Problems due to Sjögren’s found to reduce women’s quality of life
- Rise’s R-2487 moves toward clinical testing as Sjögren’s treatment
- Outcomes from Sjögren’s-associated lung disease worse in men: Study
- B-cells containing CD226 may be Sjögren’s biomarker, therapy target
- Traditional Chinese medicine QJZG may help ease Sjögren’s disease
- Sjögren’s name change marks it as ‘serious autoimmune disease’
- Telitacicept shows promise for primary Sjögren’s in Phase 3 trial
- Safety, efficacy seen for Sjögren’s therapy ianalumab in pair of trials